The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2023
Filed:
Feb. 22, 2016
Applicant:
Selecta Biosciences, Inc., Watertown, MA (US);
Inventors:
Christopher Fraser, Arlington, MA (US);
Grayson B. Lipford, Watertown, MA (US);
Christopher J. Roy, Newton, MA (US);
Roberto A. Maldonado, Jamaica Plain, MA (US);
Assignee:
Selecta Biosciences, Inc., Watertown, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 39/35 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01); A61K 9/127 (2006.01); A61K 9/51 (2006.01); A61K 38/38 (2006.01); A61K 47/50 (2017.01); A61K 47/52 (2017.01); A61K 47/54 (2017.01); A61K 47/59 (2017.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); B82Y 5/00 (2011.01); A61K 39/36 (2006.01); A61K 31/192 (2006.01); A61K 9/14 (2006.01); A61K 38/13 (2006.01); A61K 38/18 (2006.01); B82Y 40/00 (2011.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 9/127 (2013.01); A61K 9/14 (2013.01); A61K 9/51 (2013.01); A61K 9/5115 (2013.01); A61K 9/5146 (2013.01); A61K 9/5153 (2013.01); A61K 31/192 (2013.01); A61K 38/13 (2013.01); A61K 38/1816 (2013.01); A61K 38/38 (2013.01); A61K 39/00 (2013.01); A61K 39/001 (2013.01); A61K 39/0008 (2013.01); A61K 39/35 (2013.01); A61K 39/36 (2013.01); A61K 47/50 (2017.08); A61K 47/52 (2017.08); A61K 47/544 (2017.08); A61K 47/593 (2017.08); A61K 47/643 (2017.08); A61K 47/69 (2017.08); A61K 47/6923 (2017.08); A61K 47/6929 (2017.08); A61K 47/6937 (2017.08); B82Y 5/00 (2013.01); G01N 33/505 (2013.01); G01N 33/56972 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/577 (2013.01); B82Y 40/00 (2013.01); G01N 2333/7051 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/70517 (2013.01); Y02A 50/30 (2018.01);
Abstract
This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.